The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pertussis Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
The global Pertussis Vaccine market size is expected to reach US$ 6619.4 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Pertussis Vaccine in various end use industries. The expanding demands from the 12 Months Below and 12 Months Above, are propelling Pertussis Vaccine market. Whole-cell Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Acellular Vaccines segment is estimated at % CAGR for the next seven-year period.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pertussis Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pertussis Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pertussis Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pertussis Vaccine covered in this report include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc.
The global Pertussis Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Global Pertussis Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pertussis Vaccine market, Segment by Type:
Whole-cell Vaccines
Acellular Vaccines
Global Pertussis Vaccine market, by Application
12 Months Below
12 Months Above
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
The global Pertussis Vaccine market size is expected to reach US$ 6619.4 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Pertussis Vaccine in various end use industries. The expanding demands from the 12 Months Below and 12 Months Above, are propelling Pertussis Vaccine market. Whole-cell Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Acellular Vaccines segment is estimated at % CAGR for the next seven-year period.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pertussis Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pertussis Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pertussis Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pertussis Vaccine covered in this report include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc.
The global Pertussis Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Global Pertussis Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pertussis Vaccine market, Segment by Type:
Whole-cell Vaccines
Acellular Vaccines
Global Pertussis Vaccine market, by Application
12 Months Below
12 Months Above
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Pertussis Vaccine Market Overview
1.1 Pertussis Vaccine Product Overview
1.2 Pertussis Vaccine Market Segment by Type
1.2.1 Whole-cell Vaccines
1.2.2 Acellular Vaccines
1.3 Global Pertussis Vaccine Market Size by Type
1.3.1 Global Pertussis Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Pertussis Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pertussis Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pertussis Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pertussis Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pertussis Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pertussis Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pertussis Vaccine Sales Breakdown by Type (2018-2023)
2 Global Pertussis Vaccine Market Competition by Company
2.1 Global Top Players by Pertussis Vaccine Sales (2018-2023)
2.2 Global Top Players by Pertussis Vaccine Revenue (2018-2023)
2.3 Global Top Players by Pertussis Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Pertussis Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pertussis Vaccine Market Competitive Situation and Trends
2.5.1 Pertussis Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pertussis Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Pertussis Vaccine Market
2.8 Key Manufacturers Pertussis Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pertussis Vaccine Status and Outlook by Region
3.1 Global Pertussis Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pertussis Vaccine Historic Market Size by Region
3.2.1 Global Pertussis Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Pertussis Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Pertussis Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pertussis Vaccine Forecasted Market Size by Region
3.3.1 Global Pertussis Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Pertussis Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Pertussis Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pertussis Vaccine by Application
4.1 Pertussis Vaccine Market Segment by Application
4.1.1 12 Months Below
4.1.2 12 Months Above
4.2 Global Pertussis Vaccine Market Size by Application
4.2.1 Global Pertussis Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Pertussis Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pertussis Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pertussis Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pertussis Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pertussis Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pertussis Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pertussis Vaccine Sales Breakdown by Application (2018-2023)
5 North America Pertussis Vaccine by Country
5.1 North America Pertussis Vaccine Historic Market Size by Country
5.1.1 North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pertussis Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Pertussis Vaccine Sales in Value by Country (2018-2023)
5.2 North America Pertussis Vaccine Forecasted Market Size by Country
5.2.1 North America Pertussis Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Pertussis Vaccine Sales in Value by Country (2024-2029)
6 Europe Pertussis Vaccine by Country
6.1 Europe Pertussis Vaccine Historic Market Size by Country
6.1.1 Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pertussis Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Pertussis Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Pertussis Vaccine Forecasted Market Size by Country
6.2.1 Europe Pertussis Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Pertussis Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Pertussis Vaccine by Region
7.1 Asia-Pacific Pertussis Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pertussis Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pertussis Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pertussis Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Pertussis Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pertussis Vaccine Sales in Value by Region (2024-2029)
8 Latin America Pertussis Vaccine by Country
8.1 Latin America Pertussis Vaccine Historic Market Size by Country
8.1.1 Latin America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pertussis Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pertussis Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Pertussis Vaccine Forecasted Market Size by Country
8.2.1 Latin America Pertussis Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pertussis Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Pertussis Vaccine by Country
9.1 Middle East and Africa Pertussis Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pertussis Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pertussis Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pertussis Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Pertussis Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pertussis Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Company Information
10.1.2 Sanofi Pasteur Introduction and Business Overview
10.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Pasteur Pertussis Vaccine Products Offered
10.1.5 Sanofi Pasteur Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Pertussis Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 Mitsubishi Tanabe Pharma
10.3.1 Mitsubishi Tanabe Pharma Company Information
10.3.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
10.3.5 Mitsubishi Tanabe Pharma Recent Development
10.4 Wuhan Institute of Biological Products
10.4.1 Wuhan Institute of Biological Products Company Information
10.4.2 Wuhan Institute of Biological Products Introduction and Business Overview
10.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
10.4.5 Wuhan Institute of Biological Products Recent Development
10.5 Walvax Biotechnology
10.5.1 Walvax Biotechnology Company Information
10.5.2 Walvax Biotechnology Introduction and Business Overview
10.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Walvax Biotechnology Pertussis Vaccine Products Offered
10.5.5 Walvax Biotechnology Recent Development
10.6 Minhai Biotechnology
10.6.1 Minhai Biotechnology Company Information
10.6.2 Minhai Biotechnology Introduction and Business Overview
10.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Minhai Biotechnology Pertussis Vaccine Products Offered
10.6.5 Minhai Biotechnology Recent Development
10.7 KM Biologics
10.7.1 KM Biologics Company Information
10.7.2 KM Biologics Introduction and Business Overview
10.7.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 KM Biologics Pertussis Vaccine Products Offered
10.7.5 KM Biologics Recent Development
10.8 Chengdu Institute of Biological Products
10.8.1 Chengdu Institute of Biological Products Company Information
10.8.2 Chengdu Institute of Biological Products Introduction and Business Overview
10.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Products Offered
10.8.5 Chengdu Institute of Biological Products Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pertussis Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pertussis Vaccine Industrial Chain Analysis
11.4 Pertussis Vaccine Market Dynamics
11.4.1 Pertussis Vaccine Industry Trends
11.4.2 Pertussis Vaccine Market Drivers
11.4.3 Pertussis Vaccine Market Challenges
11.4.4 Pertussis Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pertussis Vaccine Distributors
12.3 Pertussis Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
